支付方在检测覆盖范围决策方面行动迟缓。
Payers move slowly on test coverage decisions.
作者信息
Carlson Bob
出版信息
Biotechnol Healthc. 2005 Aug;2(4):31-9.
Abstract
Formulary decisions might be considered a snap when compared to decisions about coverage of a genetic test. The presence - or lack - of credible data to demonstrate cost-effectiveness is usually the touchstone.
摘要
与基因检测覆盖范围的决策相比，药品处方集决策可能被认为是轻而易举的。有无可靠数据来证明成本效益通常是试金石。
相似文献
1
Payers move slowly on test coverage decisions.支付方在检测覆盖范围决策方面行动迟缓。
Biotechnol Healthc. 2005 Aug;2(4):31-9.
2
Real-World Evidence: Bridging Gaps in Evidence to Guide Payer Decisions.真实世界证据：弥合证据差距以指导支付方决策。
Pharmacoecon Open. 2021 Mar;5(1):3-11. doi: 10.1007/s41669-020-00221-y.
3
Mapping US commercial payers' coverage policies for medical interventions.绘制美国商业支付方对医疗干预措施的覆盖政策图谱。
Am J Manag Care. 2016 Sep 1;22(9):e323-8.
4
Factors predicting Medicare national coverage: an empirical analysis.预测医疗保险全国覆盖的因素：实证分析。
Med Care. 2012 Mar;50(3):249-56. doi: 10.1097/MLR.0b013e318241eb40.
5
A framework to guide the optimal development and use of real-world evidence for drug coverage and formulary decisions.一个指导为药物覆盖范围和处方集决策优化开发和使用真实世界证据的框架。
J Comp Eff Res. 2018 Dec;7(12):1145-1152. doi: 10.2217/cer-2018-0059. Epub 2018 Nov 14.
6
Cost shifting and timeliness of drug formulary decisions in atlantic Canada.加拿大东部地区药品处方集决策中的成本转嫁与及时性
Healthc Policy. 2010 Feb;5(3):100-14.
7
Decision-making by healthcare payers.医疗保健支付方的决策制定
Respir Med. 2002 Aug;96 Suppl C:S31-8. doi: 10.1016/s0954-6111(02)80032-4.
8
Guidelines and Value-Based Decision Making: An Evolving Role for Payers.指南与基于价值的决策制定：支付方角色的不断演变
N C Med J. 2015 Sep-Oct;76(4):243-6. doi: 10.18043/ncm.76.4.243.
9
Costs and spillover effects of private insurers' coverage of hepatitis C treatment.私人保险公司对丙型肝炎治疗的承保成本及溢出效应。
Am J Manag Care. 2016 May;22(6 Spec No.):SP236-44.
10
[GRADE: Evidence to Decision (EtD) framework for coverage decisions].[分级：用于覆盖决策的证据到决策（EtD）框架]
Z Evid Fortbild Qual Gesundhwes. 2020 Apr;150-152:134-141. doi: 10.1016/j.zefq.2020.03.002. Epub 2020 May 22.
引用本文的文献
1
The strategic defense of physician autonomy: State public health agencies as countervailing powers.医师自主权的战略防御：作为抗衡力量的州公共卫生机构。
Soc Sci Med. 2017 Aug;186:113-121. doi: 10.1016/j.socscimed.2017.06.007. Epub 2017 Jun 3.
Zotero 插件